Intensity-Modulated Radiation Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Medicare Overpaid Hospitals $26 Million for IMRT Medicare Overpaid Hospitals $26 Million for IMRT
Medicare has inadvertently overpaid hospitals nearly $26 million for outpatient intensity-modulated radiation therapy (IMRT) planning services because of improper billing.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

HHS audit finds hospitals overbill for IMRT planning
The Medicare system overpaid U.S. hospitals by nearly $26 million for...Read more on AuntMinnie.comRelated Reading: OIG questions some meaningful use payments NY mobile imaging firm hit by OIG investigation Federal probe confirms scheduling woes at Phoenix VA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 22, 2018 Category: Radiology Source Type: news

Is radiation therapy warranted for DCIS postlumpectomy?
Researchers have found that radiation therapy after lumpectomy in women with...Read more on AuntMinnie.comRelated Reading: Microbubbles improve breast cancer radiation therapy ASTRO: Short radiation course safe for breast cancer LED device could predict skin damage from breast RT Robotic IMRT-APBI works well for breast cancer patients SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news

Radiation Therapy Can Increase Mesothelioma Survival Time
Too many patients with malignant pleural mesothelioma are going without adjuvant radiotherapy that could extend their lives significantly, according to Dr. Bin Teh at Houston Methodist Hospital in Texas. Teh is the senior author of a recent study — the largest of its kind — that examined the role and extent of radiation therapy in the overall treatment of mesothelioma. He and his colleagues found only 3.1 percent of patients diagnosed with pleural mesothelioma underwent radiotherapy treatment in combination with aggressive surgery. “Surgery plus radiation improves overall survival,” Teh, vice chair of the Departmen...
Source: Asbestos and Mesothelioma News - July 30, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies
PALO ALTO, Calif., April 19, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it is incorporating new imaging technologies in the Halcyon 2.0 treatment system to expand its capabilities and ability to deliver high qual... Devices, Oncology Varian Medical Systems, Halcyon System, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

Pleurectomy and Decortication the ‘ Way to Go ’ for Mesothelioma
Dr. Pietro Bertoglio and his colleagues at the University Hospital of Pisa stopped performing the aggressive extrapleural pneumonectomy (EPP) surgery for mesothelioma more than a decade ago. They believe it’s long overdue for everyone else to do the same and instead use the less-debilitating pleurectomy/decortication (P/D) procedure. The Journal of Thoracic and Cardiovascular Surgery recently published the University Hospital of Pisa’s 10-year experience using P/D and hyperthermic intrathoracic chemotherapy (HITHOC). Two editorial commentaries from thoracic surgeons in the U.S. accompanied the study from Italy, support...
Source: Asbestos and Mesothelioma News - April 16, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Proton RT for Prostate Cancer Has Reduced Toxicity, Higher Cost vs Other RT Options
Proton radiation therapy offers some reduced toxicity over IMRT in patients under the age of 65 with prostate cancer, but its cost is nearly double. (Source: CancerNetwork)
Source: CancerNetwork - March 26, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers News Prostate Cancer Source Type: news

Varian Halcyon Treatment System Receives AERB Certificate for Import & amp; Supply in India
PALO ALTO, Calif. and MUMBAI, India - Feb. 6, 2018 - Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows Varian to now market this new system in India. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is well suited to treat a majority of cancer patients, offering...This story is related to the following:Clinical Medical Equipment (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - February 7, 2018 Category: Medical Devices Source Type: news

Varian Medical acquires Mobius Medical Systems
Varian Medical (NYSE:VAR) said yesterday it bought radiation oncology quality assurance software maker Mobius Medical Systems for an undisclosed amount. The Palo Alto, Calif.-based company said the acquisition will be beneficial to its portfolio of patient treatment plan QA and machine QA technologies, and that integration of the Mobius’ technologies will enable advanced QA processes to be “seamlessly combined into treatment workflows.” Mobius’ QA software is currently in use at over 1,000 sites globally, and includes the Mobius3D dose verification and IMRT/VMAT treatment delivery system, the comp...
Source: Mass Device - February 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Software / IT mobiusmedicalsystems Varian Medical Systems Source Type: news

Varian Halcyon Treatment System Receives AERB Certificate for Import and Supply in India
PALO ALTO, Calif. and MUMBAI, India, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced the Halcyon cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply i... Devices, Oncology, Regulatory Varian Medical Systems, Halcyon, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

No Reduced Toxicity for Proton Tx vs IMRT in NSCLC (CME/CE)
(MedPage Today) -- Study challenges assumptions about supposed superiority of proton therapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 4, 2018 Category: Hematology Source Type: news

Microbubbles improve breast cancer radiation therapy
Injecting breast cancer with oxygen-filled microbubbles makes tumors three...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer LED device could predict skin damage from breast RT NEJM: RT boosts heart disease risk in breast cancer patients Robotic IMRT-APBI works well for breast cancer patients SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2018 Category: Radiology Source Type: news

Proton Therapy Not Better Than IMRT in Lung Cancer Proton Therapy Not Better Than IMRT in Lung Cancer
In a randomized trial comparing the two modalities, proton therapy was not superior in reducing the rate of serious lung toxicityMedscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 18, 2018 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Varian inks Chinese cancer care deal with Ping An, wins Taiwanese nod for Halcyon
Varian Medical (NYSE:VAR) said today it signed a strategic partnership deal with Ping An Health Technology to explore expanding cancer care in China, and that it won Taiwanese approval for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. In its deal with Ping An, Palo Alto, Calif.-based Varian said both companies will explore using artificial intelligence, cloud computing and big data tech to bring high quality, cost-effective cancer care to more individuals in China. “We are pleased to be collaborating with Ping An, the leading force in the field of healthcare in Chin...
Source: Mass Device - January 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Regulatory/Compliance Varian Medical Systems Source Type: news

Varian Halcyon Treatment System Receives Taiwan FDA Approval
PALO ALTO, Calif., Jan. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced its Halcyon system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This appr... Devices, Oncology, Regulatory Varian Medical Systems, Halcyon, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2018 Category: Pharmaceuticals Source Type: news